Mark Kowalski Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Kowalski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Kowalski. Mark Kowalski is a Chief Medical Officer in ProNAi Therapeutics Inc ($DNAI) and a Sr VP & Chief Medical Officer in Arbutus Biopharma Corp ($TKMR).
Address: C/O TEKMIRA PHARMACEUTICALS CORP. SUITE 100, 8900 GLENLYON PARKWAY BURNABY V5J 5J8 A1
Companies in which Mark Kowalski is an Insider
Arbutus Biopharma Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Kowalski: Sr VP & Chief Medical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 17 2016
$TKMR Market Capitalization: $138.47M
$TKMR Previous Close: $2.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sierra Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Kowalski: Chief Medical Officer
Holdings: 0 shares
Latest Transaction: Mar 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark Kowalski
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | SRRA | Sierra Oncology, I ... | Kowalski Mark | Chief Medical Offic ... | Option Exercise | A | 16.73 | 30,000 | 501,900 | 30,000 | |
| Aug 12 2020 | SRRA | Sierra Oncology, I ... | Kowalski Mark | Chief Medical Offic ... | Option Exercise | A | 12.15 | 24,970 | 303,386 | 24,970 | |
| Aug 12 2020 | SRRA | Sierra Oncology, I ... | Kowalski Mark | Chief Medical Offic ... | Option Exercise | A | 12.15 | 24,970 | 303,386 | 24,970 | |
| Mar 05 2019 | SRRA | Sierra Oncology, I ... | Kowalski Mark | Chief Medical Offic ... | Option Exercise | A | 1.96 | 200,000 | 392,000 | 200,000 | |
| Mar 07 2018 | SRRA | Sierra Oncology, I ... | Kowalski Mark | Chief Medical Offic ... | Option Exercise | A | 2.36 | 155,000 | 365,800 | 155,000 | |
| Jan 04 2017 | DNAI | ProNAi Therapeutic ... | Kowalski Mark | Chief Medical Offic ... | Option Exercise | A | 1.54 | 300,000 | 462,000 | 300,000 | |
| Mar 17 2016 | TKMR | Arbutus Biopharma ... | Kowalski Mark | Sr VP & Chief Medic ... | Option Exercise | A | 3.94 | 85,000 | 334,900 | 85,000 |